Actively Recruiting
Improving Viral Suppression in Youth With HIV Using Choice Counseling and Long-Acting Injectable Treatment
Led by Johns Hopkins University · Updated on 2026-02-04
288
Participants Needed
1
Research Sites
37 weeks
Total Duration
AI-Summary
What This Trial Is About
Adolescents and young adults aged 12 to 30 years living with HIV often face challenges in achieving viral suppression due to social, cognitive, system, and biomedical factors. This research evaluates strategies to improve viral suppression by optimizing antiretroviral treatment ART choices, including the option of long-acting injectable ART LAI-ART, aiming to reduce disparities and improve health outcomes in this key population. The study involves counseling participants using the HIV-ASSIST clinical program to help them choose between continuing oral ART or switching to LAI-ART. Participants who prefer LAI-ART receive support from a specialized team to overcome barriers to accessing this treatment. Those who are not virally suppressed undergo frequent monitoring and re-counseling if suppression is achieved. The study does not provide the ART drugs but facilitates access and support. Participants attend assessments at baseline, 3, 6, 9, and 12 months to evaluate viral suppression, quality of life, self-efficacy, treatment adherence barriers, and HIV stigma. The study also examines implementation challenges and cost-effectiveness of the intervention. Total participation lasts one year with ongoing monitoring to assess these outcomes and support informed treatment choices for youth with HIV.
CONDITIONS
Brief Title
Strategies to AchieVe Viral Suppression for Youth With HIV
Research Team
A
Allison Agwu, MD, SCM
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here